Follow the people · Insider
Sarah Joanne Williams
Sarah Joanne Williams files insider transactions with the SEC as a principal accounting officer of AN2 Therapeutics (ANTX). We hold 3 disclosed purchases and sales filed since 23 February 2026, 1 of them in the last 90 days.
- Files forANTX
- Disclosed buys and sells3 in all, 1 in the last 90 days
- Last disclosure4 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 20 February 2026 — 1 September 2026Principal Accounting Officer · AN2 Therapeutics (ANTX)6 Form 4 lines · source: SEC Form 4
Everything they disclosed
6 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 272 shares of AN2 TherapeuticsSEC Form 44 September 2026Common Stock · traded 1 September 2026 · filed 4 September 2026
- ▼ sold on the open market 265 shares of AN2 TherapeuticsSEC Form 42 June 2026Common Stock · traded 29 May 2026 · filed 2 June 2026
- ▼ sold on the open market 327 shares of AN2 TherapeuticsSEC Form 45 March 2026Common Stock · traded 3 March 2026 · filed 5 March 2026
- ▼ sold on the open market 327 shares of AN2 TherapeuticsSEC Form 45 March 2026Common Stock · traded 3 March 2026 · filed 5 March 2026
- was granted 48,375 shares of AN2 TherapeuticsSEC Form 423 February 2026Common Stock · traded 20 February 2026 · filed 23 February 2026
- was granted 48,375 shares of AN2 TherapeuticsSEC Form 423 February 2026Common Stock · traded 20 February 2026 · filed 23 February 2026
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.